Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.
Reset all filters
01 1Minakem
02 1ChemWerth Inc
03 1Minakem (formerly Delmar Chemicals)
04 1Transo-Pharm USA LLC
05 1LGM Pharma
06 1Zeon Pharma Industries India Pvt Ltd
07 1ALP Pharm
08 1Cipla
09 1Eriochem S.A.
10 1Exopharm
11 1Guangzhou Hanfang Pharma. Co. Ltd
12 2Hansoh Pharma
13 1Hubei Honch Pharmaceutical
14 2Pierre Fabre
15 1Qilu Pharmaceutical
16 2Synbias Pharma Limited Liability Company
17 1Tecoland Corporation
18 1Zhejiang Hisun Pharmaceutical
19 1Blank
Reset all filters
01 1Argentina
02 1Australia
03 1Canada
04 7China
05 3France
06 2India
07 4U.S.A
08 2Ukraine
09 1Blank
Reset all filters
01 4Active
02 12Inactive
03 6Blank
01 1Expired
02 4Valid
03 3Withdrawn by Holder
04 14Blank
Reset all filters
01 1218MF10576
02 1226MF10027
03 1303MF10150
04 1303MF10173
05 18Blank
Reset all filters
01 22Blank
Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-04-23
Pay. Date : 2016-03-23
DMF Number : 14619
Submission : 1999-12-13
Status : Active
Type : II
Certificate Number : R1-CEP 2011-342 - Rev 00
Issue Date : 2018-08-06
Type : Chemical
Substance Number : 2107
Status : Valid
Registration Number : 303MF10150
Registrant's Address : Rue Fonds Jean Pa(^)ques, 8 1435 Mont-Saint-Guibert Belgium
Initial Date of Registration : 2021-09-17
Latest Date of Registration :
NDC Package Code : 69910-0004
Start Marketing Date : 2015-06-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-05-10
Pay. Date : 2017-03-14
DMF Number : 31480
Submission : 2017-04-13
Status : Active
Type : II
Registration Number : 226MF10027
Registrant's Address : 9 Dongjin Road, Economic & Technical Development Zone, Lianyungang, Jiangsu 222069, China
Initial Date of Registration : 2014-02-05
Latest Date of Registration :
NDC Package Code : 66529-0001
Start Marketing Date : 2010-06-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-11-02
Pay. Date : 2015-06-11
DMF Number : 26091
Submission : 2013-12-30
Status : Active
Type : II
Certificate Number : CEP 2009-394 - Rev 06
Issue Date : 2024-04-11
Type : Chemical
Substance Number : 2107
Status : Valid
NDC Package Code : 62158-0001
Start Marketing Date : 2014-02-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9477
Submission : 1991-11-25
Status : Active
Type : II
Certificate Number : R1-CEP 2004-297 - Rev 05
Issue Date : 2020-02-25
Type : Chemical
Substance Number : 2107
Status : Valid
Registration Number : 218MF10576
Registrant's Address : 16 rue Jean Rostand ZI de Clergous 81600 GAILLAC FRANCE
Initial Date of Registration : 2006-06-15
Latest Date of Registration :
Registrant Name : Bukwang Pharmaceutical Co., Ltd.
Registration Date : 2005-08-31
Registration Number : 20050831-57-A-111-01
Manufacturer Name : Pierre Fabre Medicine
Manufacturer Address : Zone Industrielle des Clergous, 16 rue Jean Rostand - 81600 Gaillac, France
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21929
Submission : 2008-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 28221
Submission : 2014-05-06
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20158
Submission : 2009-02-19
Status : Inactive
Type : II
Certificate Number : R1-CEP 2008-191 - Rev 01
Issue Date : 2015-04-13
Type : Chemical
Substance Number : 2107
Status : Withdrawn by Holder
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23951
Submission : 2010-06-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25783
Submission : 2012-02-13
Status : Inactive
Type : II
Certificate Number : R0-CEP 2016-009 - Rev 01
Issue Date : 2018-06-29
Type : Chemical
Substance Number : 2107
Status : Expired
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15956
Submission : 2002-04-25
Status : Inactive
Type : II
Certificate Number : R1-CEP 2005-146 - Rev 01
Issue Date : 2012-06-26
Type : Chemical
Substance Number : 2107
Status : Withdrawn by Holder
Registrant Name : Korea Sandoz Co., Ltd.
Registration Date : 2006-05-03
Registration Number : 20060503-57-A-194-02
Manufacturer Name : Zhejiang Hisun Pharmaceutical. Co., Ltd.
Manufacturer Address : 46Waisha Road, Jiaojiang District Taizhou City, Zhejiang Province 318000 People`s Republic of China
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16011
Submission : 2002-06-14
Status : Inactive
Type : II
Certificate Number : R1-CEP 2017-075 - Rev 00
Issue Date : 2023-02-21
Type : Chemical
Substance Number : 2107
Status : Valid
Registration Number : 303MF10173
Registrant's Address : 9 Dongjin Road, Economic & Technical Development Zone, Lianyungang, Jiangsu 222069, China
Initial Date of Registration : 2021-12-09
Latest Date of Registration :
NDC Package Code : 66529-0001
Start Marketing Date : 2010-06-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25203
Submission : 2011-07-30
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16706
Submission : 2003-07-14
Status : Inactive
Type : II
Certificate Number : R1-CEP 2007-255 - Rev 01
Issue Date : 2018-06-18
Type : Chemical
Substance Number : 2107
Status : Withdrawn by Holder
Registrant Name : Korea Pfizer Pharmaceutical Co., Ltd.
Registration Date : 2007-01-26
Registration Number : 20070126-57-A-201-03
Manufacturer Name : Eriochem SA
Manufacturer Address : Ruta 12-Km 452 Colonia Avellaneda, Departament Parana Entre Rios, Argentina
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19094
Submission : 2006-01-03
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9973
Submission : 1992-11-23
Status : Inactive
Type : II
Registrant Name : Bukwang Pharmaceutical Co., Ltd.
Registration Date : 2005-08-31
Registration Number : 20050831-57-A-111-01
Manufacturer Name : Pierre Fabre Medicine
Manufacturer Address : Zone Industrielle des Clergous, 16 rue Jean Rostand - 81600 Gaillac, France
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8097
Submission : 1989-06-08
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
32
PharmaCompass offers a list of Vinorelbine Tartrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Vinorelbine Tartrate manufacturer or Vinorelbine Tartrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Vinorelbine Tartrate manufacturer or Vinorelbine Tartrate supplier.
PharmaCompass also assists you with knowing the Vinorelbine Tartrate API Price utilized in the formulation of products. Vinorelbine Tartrate API Price is not always fixed or binding as the Vinorelbine Tartrate Price is obtained through a variety of data sources. The Vinorelbine Tartrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Vinorelbine Tartrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vinorelbine Tartrate, including repackagers and relabelers. The FDA regulates Vinorelbine Tartrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vinorelbine Tartrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Vinorelbine Tartrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Vinorelbine Tartrate supplier is an individual or a company that provides Vinorelbine Tartrate active pharmaceutical ingredient (API) or Vinorelbine Tartrate finished formulations upon request. The Vinorelbine Tartrate suppliers may include Vinorelbine Tartrate API manufacturers, exporters, distributors and traders.
click here to find a list of Vinorelbine Tartrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 18 companies offering Vinorelbine Tartrate
Get in contact with the supplier of your choice: